Fulcrum Therapeutics (FULC) Change in Cash (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Change in Cash data on file, last reported at -$147.3 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 818.5% year-over-year to -$147.3 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a 262.63% increase from a year earlier, with the FY2025 full-year figure at $139.3 million, up 325.3% from the prior year.
• Change in Cash for Q1 2026 stood at -$147.3 million, down from $150.5 million in the prior quarter.
• Over the last five years, Change in Cash for FULC reached as high as $150.5 million in Q4 2025 and fell as low as -$147.3 million in Q1 2026.
• Historically, Change in Cash has averaged $879882.4 across 5 years, with a median of -$768000.0 in 2023.
• Across the five-year window, Change in Cash surged 6189.58% in 2024 and tumbled 818.5% in 2026, its largest moves.
• Year by year, Change in Cash stood at -$55.8 million in 2022, then jumped by 91.91% to -$4.5 million in 2023, then plunged by 219.19% to -$14.4 million in 2024, then soared by 1143.52% to $150.5 million in 2025, then plunged by 197.88% to -$147.3 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$147.3 million in Q1 2026, $150.5 million in Q4 2025, and $4.5 million in Q3 2025.